Amgen Inc (NASDAQ:AMGN)

243.29
Delayed Data
As of Sep 21
 -4.53 / -1.83%
Today’s Change
177.05
Today|||52-Week Range
264.97
+0.92%
Year-to-Date
Trump's Pep Talk Raises Vaccine Hopes: 4 Stocks to Watch
Sep 21 / Zacks.com - Paid Partner Content
The 5 Undervalued Blue Chip High Dividend Growth Stocks You Need To Buy Now
Sep 20 / Seeking Alpha - Paid Partner Content
Dow Jones Changes Could Impact Investor Portfolios
Sep 21 / MotleyFool.com - Paid Partner Content
Sector Watch: More oncology events as cancer ETF breaks out
Sep 20 / Seeking Alpha - Paid Partner Content
Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)?
Sep 21 / Zacks.com - Paid Partner Content
Amgen: Growing At A Reasonable Price
Sep 20 / Seeking Alpha - Paid Partner Content
Amgen's sotorasib shows encouraging clinical benefit in KRAS G12C-mutant tumors
Sep 21 / Seeking Alpha - Paid Partner Content
Where Will Amgen Be in 1 Year?
Sep 19 / MotleyFool.com - Paid Partner Content
Moderna CEO: It's All or Nothing
Sep 20 / GuruFocus News - Paid Partner Content
Seeking Alpha Catalyst Watch
Sep 18 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close247.72
Today’s open247.04
Day’s range238.20 - 247.04
Volume2,745,529
Average volume (3 months)2,742,446
Market cap$145.1B
Data as of 3:59pm ET, 09/21/2020

Growth & Valuation

Earnings growth (last year)+2.07%
Earnings growth (this year)+6.39%
Earnings growth (next 5 years)+7.07%
Revenue growth (last year)-2.13%
P/E ratio19.9
Price/Sales6.31
Price/Book15.15

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.84-1.29%
BIIBBiogen-6.18-2.25%
ILMNIllumina Inc-25.37-8.59%
MRNAModerna Inc-0.61-0.87%
Data as of 4:54pm ET, 09/21/2020

Financials

Next reporting dateNovember 3, 2020
EPS forecast (this quarter)$3.80
Annual revenue (last year)$23.3B
Annual profit (last year)$7.8B
Net profit margin33.71%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Thousand Oaks, California

Forecasts